Additionally, patients with MAFLD exhibited distinct differences in body composition, such as older age, higher body mass index, and higher levels of alanine aminotransferase (ALT), triglycerides, and waist circumference compared to NAFLD patients (28). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.